{"id":366,"date":"2022-05-02T13:42:23","date_gmt":"2022-05-02T13:42:23","guid":{"rendered":"https:\/\/oligofastx.com\/?page_id=366"},"modified":"2022-07-27T11:23:36","modified_gmt":"2022-07-27T11:23:36","slug":"colaboradores","status":"publish","type":"page","link":"https:\/\/oligofastx.com\/es\/colaboradores\/","title":{"rendered":"Colaboradores"},"content":{"rendered":"\n  <div class=\"banner has-hover\" id=\"banner-40526337\">\n          <div class=\"banner-inner fill\">\n        <div class=\"banner-bg fill\" >\n            <div class=\"bg fill bg-fill \"><\/div>\n                                    \n                    <\/div>\n\t\t\n        <div class=\"banner-layers container\">\n            <div class=\"fill banner-link\"><\/div>            \n   <div id=\"text-box-2548617\" class=\"text-box banner-layer x50 md-x50 lg-x50 y50 md-y50 lg-y50 res-text\">\n                                <div class=\"text-box-content text dark\">\n              \n              <div class=\"text-inner text-center\">\n                  \n<h2 class=\"lead\">Colaboradores<\/h2>\n              <\/div>\n           <\/div>\n                            \n<style>\n#text-box-2548617 {\n  width: 60%;\n}\n#text-box-2548617 .text-box-content {\n  font-size: 100%;\n}\n<\/style>\n    <\/div>\n \n        <\/div>\n      <\/div>\n\n            \n<style>\n#banner-40526337 {\n  padding-top: 161px;\n}\n#banner-40526337 .bg.bg-loaded {\n  background-image: url(https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/medical-scientist-in-hazmat-suit-working-with-micr-2022-01-18-23-41-28-utc1-1400x576.jpg);\n}\n<\/style>\n  <\/div>\n\n\n<div class=\"row\"  id=\"row-1080616395\">\n\n\t<div id=\"col-323520245\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"text-2037875628\" class=\"text\">\n\t\t\n<p class=\"lead text-center\"><strong><span style=\"color: #887b4e;\">Las empresas participantes en OLIGOFASTX cuentan con la colaboraci\u00f3n y apoyo de un importante n\u00famero de centros p\u00fablicos espa\u00f1oles de I+D espa\u00f1oles punteros tecnolog\u00edas relacionadas con los oligonucle\u00f3tidos y en la investigaci\u00f3n en enfermedades raras, desarrollo de f\u00e1rmacos, liberaci\u00f3n de principios activos y nuevos m\u00e9todos producci\u00f3n relacionadas con la aplicaci\u00f3n de oligonucle\u00f3tidos en salud humana.\u00a0<\/span><\/strong><\/p>\n\t\t\n<style>\n#text-2037875628 {\n  font-size: 1.2rem;\n}\n<\/style>\n\t<\/div>\n\t\n<div class=\"text-center\"><div class=\"is-divider divider clearfix\" ><\/div><\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-1651369680\">\n\n\t<div id=\"col-1627051336\" class=\"col small-12 large-12\"  data-animate=\"fadeInRight\">\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(136, 123, 78);border-radius:25px;border-width:0px 0px 5px 5px;\">\n\t<\/div>\n\t\t\t\n<table>\n<tbody>\n<tr style=\"color: black;\">\n<td width=\"115\">\u00a0<\/td>\n<td style=\"text-align: center;\" width=\"115\">\n<p><span style=\"font-size: 110%;\"><strong><span style=\"color: #808080;\">Colaborador<\/span><\/strong><\/span><\/p>\n<\/td>\n<td width=\"121\">\n<p style=\"text-align: center;\"><span style=\"font-size: 110%;\"><strong><span style=\"color: #808080;\">Campo de especializaci\u00f3n<\/span><\/strong><\/span><\/p>\n<\/td>\n<td width=\"353\">\n<p style=\"text-align: center;\"><span style=\"font-size: 110%;\"><strong><span style=\"color: #808080;\">Descripci\u00f3n<\/span><\/strong><\/span><\/p>\n<\/td>\n<td style=\"text-align: center;\"><span style=\"font-size: 110%;\"><strong><span style=\"color: #808080;\">\u00a0AREA DEL PROYECTO<\/span><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"115\">\n<p><a href=\"https:\/\/www.iqac.csic.es\/research\/departments\/surfactants-and-nanobiotechnology\/nucleic-acids-chemistry\/\"><span style=\"font-size: 110%;\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-619 size-medium alignnone\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_iqac_csic-800x216.png\" alt=\"\" width=\"800\" height=\"216\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_iqac_csic-800x216.png 800w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_iqac_csic-768x208.png 768w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_iqac_csic.png 884w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><\/span><\/a><\/p>\n<\/td>\n<td width=\"115\">\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.iqac.csic.es\/research\/departments\/surfactants-and-nanobiotechnology\/nucleic-acids-chemistry\/\"><strong><span style=\"font-size: 110%;\">IQAC-CSIC<\/span><\/strong><\/a><\/p>\n<\/td>\n<td width=\"121\">\n<p><span style=\"font-size: 110%;\">S\u00edntesis Qu\u00edmica<\/span><\/p>\n<p><span style=\"font-size: 110%;\">\u00c1cidos nucleicos<\/span><\/p>\n<\/td>\n<td width=\"353\">\n<p><span style=\"font-size: 110%;\">El grupo del Dr. Ram\u00f3n Eritja,\u00a0 del del Instituto de qu\u00edmica Aplicada de Catalu\u00f1a (IQAC) del Consejo Superior de Investigaciones Cient\u00edficas (CSIC), es un grupo de investigaci\u00f3n reconocido internacionalmente\u00a0 en en el campo de la qu\u00edmica\u00a0 y s\u00edntesis de \u00e1cidos nucleicos.<\/span><\/p>\n<\/td>\n<td>\n<figure id=\"attachment_605\" aria-describedby=\"caption-attachment-605\" style=\"width: 122px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-605\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_04.png\" alt=\"\" width=\"122\" height=\"122\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_04.png 401w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_04-280x280.png 280w\" sizes=\"auto, (max-width: 122px) 100vw, 122px\" \/><figcaption id=\"caption-attachment-605\" class=\"wp-caption-text\">Producci\u00f3n y escalado<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"115\">\n<p><a href=\"https:\/\/www.umh.es\/contenido\/pdi\/:uor_900_36\/datos_es.html\"><span style=\"font-size: 110%;\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-620 aligncenter\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_Miguel_Hernandez.png\" alt=\"\" width=\"384\" height=\"132\" \/><\/span><\/a><\/p>\n<\/td>\n<td width=\"115\">\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.umh.es\/contenido\/pdi\/:uor_900_36\/datos_es.html\"><strong><span style=\"font-size: 110%;\">Universidad Miguel Hern\u00e1ndez<\/span><\/strong><\/a><\/p>\n<\/td>\n<td width=\"121\">\n<p><span style=\"font-size: 110%;\">Investigaci\u00f3n neurobiolog\u00eda.<\/span><\/p>\n<p><span style=\"font-size: 110%;\">Oftalmolog\u00eda.<\/span><\/p>\n<p>\u00a0<\/p>\n<\/td>\n<td width=\"353\">\n<p><span style=\"font-size: 110%;\">Grupo de investigaci\u00f3n del Profesor Eduardo F\u00e9rnandez, Jefe del Departamento de Histolog\u00eda y Anatom\u00eda de la Universidad Miguel Hern\u00e1ndez (Espa\u00f1a) y Director de la Unidad de Neuroingenier\u00eda y Neuropr\u00f3tesis del Instituto de Bioingenier\u00eda, especializado en interfaces humanos del sistema nervioso central, incluyendo estudio de \u00f3rganos como la retina.<\/span><\/p>\n<\/td>\n<td>\n<figure id=\"attachment_604\" aria-describedby=\"caption-attachment-604\" style=\"width: 122px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-604\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png\" alt=\"\" width=\"122\" height=\"122\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png 401w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03-280x280.png 280w\" sizes=\"auto, (max-width: 122px) 100vw, 122px\" \/><figcaption id=\"caption-attachment-604\" class=\"wp-caption-text\">Desarrollo de terapias<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"115\">\n<p><a href=\"https:\/\/www.irbbarcelona.org\/en\/research\/molecular-modelling-and-bioinformatics\"><span style=\"font-size: 110%;\"><img decoding=\"async\" class=\"wp-image-621 aligncenter\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IRB.svg\" alt=\"\" width=\"70\" \/><\/span><\/a><\/p>\n<\/td>\n<td width=\"115\">\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.irbbarcelona.org\/en\/research\/molecular-modelling-and-bioinformatics\" target=\"_blank\" rel=\"noopener\"><strong><span style=\"font-size: 110%;\">IRB<\/span><\/strong><\/a><\/p>\n<\/td>\n<td width=\"121\">\n<p><span style=\"font-size: 110%;\">Modelizaci\u00f3n molecular.<\/span><\/p>\n<p><span style=\"font-size: 110%;\">(modelizaci\u00f3n y dise\u00f1o computacional de mol\u00e9culas)<\/span><\/p>\n<p>\u00a0<\/p>\n<\/td>\n<td width=\"353\">\n<p><span style=\"font-size: 110%;\">El grupo del profesor Modesto Orozco est\u00e1 especializado en el estudio de mecanismos pat\u00f3genos y en el dise\u00f1o de modelizaci\u00f3n molecular mediante herramientas inform\u00e1ticas. A lo largo de sus carrera ha se ha centrado en gran parte en el estudio de modelizaci\u00f3n molecular, estudio de la estructura y caracterizaci\u00f3n de \u00e1cidos nucleicos.<\/span><\/p>\n<\/td>\n<td>\n<figure id=\"attachment_602\" aria-describedby=\"caption-attachment-602\" style=\"width: 122px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-602\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_01.png\" alt=\"\" width=\"122\" height=\"122\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_01.png 401w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_01-280x280.png 280w\" sizes=\"auto, (max-width: 122px) 100vw, 122px\" \/><figcaption id=\"caption-attachment-602\" class=\"wp-caption-text\">Dise\u00f1o, modelizaci\u00f3n e IA<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"115\">\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.uma.es\/departamento-de-biologia-molecular-y-bioquimica\/#:~:text=El%20departamento%20de%20Biolog%C3%ADa%20Molecular,de%20Bioqu%C3%ADmica%20y%20Biolog%C3%ADa%20Molecular.\"><span style=\"font-size: 110%;\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-635 aligncenter\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_universidad_de_malaga-750x400.png\" alt=\"\" width=\"750\" height=\"400\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_universidad_de_malaga-750x400.png 750w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_universidad_de_malaga-1400x747.png 1400w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_universidad_de_malaga-768x410.png 768w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_universidad_de_malaga-1536x819.png 1536w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_universidad_de_malaga.png 1772w\" sizes=\"auto, (max-width: 750px) 100vw, 750px\" \/><\/span><\/a><\/p>\n<\/td>\n<td width=\"115\">\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.uma.es\/departamento-de-biologia-molecular-y-bioquimica\/#:~:text=El%20departamento%20de%20Biolog%C3%ADa%20Molecular,de%20Bioqu%C3%ADmica%20y%20Biolog%C3%ADa%20Molecular.\" target=\"_blank\" rel=\"noopener\"><strong><span style=\"font-size: 110%;\">Universidad de M\u00e1laga<\/span><\/strong><\/a><\/p>\n<\/td>\n<td width=\"121\">\n<p><span style=\"font-size: 110%;\">B\u00fasqueda de nuevas dianas para tratamiento de enfermedades raras.<\/span><\/p>\n<\/td>\n<td width=\"353\">\n<p><span style=\"font-size: 110%;\">El grupo de investigaci\u00f3n del Dr. Ranea de Biocomputaci\u00f3n del Departamento de Biolog\u00eda Molecular y Bioqu\u00edmica de la Universidad de M\u00e1laga (UMA) es experto en la b\u00fasqueda de nuevas dianas terap\u00e9uticas en enfermedades raras, mediante estrategias de Inteligencia Artificial y Biolog\u00eda de Sistemas.<\/span><\/p>\n<\/td>\n<td>\n<figure id=\"attachment_604-2\" aria-describedby=\"caption-attachment-604-2\" style=\"width: 122px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-604\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png\" alt=\"\" width=\"122\" height=\"122\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png 401w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03-280x280.png 280w\" sizes=\"auto, (max-width: 122px) 100vw, 122px\" \/><figcaption id=\"caption-attachment-604-2\" class=\"wp-caption-text\">Desarrollo de terapias<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"115\">\n<p style=\"text-align: center;\"><a href=\"http:\/\/www.cajal.csic.es\/departamentos\/fernando-decastro\/personal.html\"><span style=\"font-size: 110%;\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-636 aligncenter\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_Instituto_Cajal.jpg\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_Instituto_Cajal.jpg 300w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_Instituto_Cajal-280x280.jpg 280w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><\/a><\/p>\n<\/td>\n<td width=\"115\">\n<p style=\"text-align: center;\"><a href=\"http:\/\/www.cajal.csic.es\/departamentos\/fernando-decastro\/personal.html\" target=\"_blank\" rel=\"noopener\"><strong><span style=\"font-size: 110%;\">Instituto Cajal &#8211; CSIC<\/span><\/strong><\/a><\/p>\n<\/td>\n<td width=\"121\">\n<p><span style=\"font-size: 110%;\">Neuritis Autoinmune Experimental<\/span><\/p>\n<p><span style=\"font-size: 110%;\">Encefalomielitis Autoinmune Experimental<\/span><\/p>\n<p><span style=\"font-size: 110%;\">S\u00edndrome Guillain-Barre<\/span><\/p>\n<\/td>\n<td width=\"353\">\n<p><span style=\"font-size: 110%;\">El grupo de Grupo de Neurobiolog\u00eda del Desarrollo-GNDe del Instituto Cajal del Consejo Superior de Investigaciones Cient\u00edficas (CSIC), dirigido por del Dr. Fernando de Castro, es experto en el estudio de la patogenia de las enfermedades desmielinizantes, como la esclerosis m\u00faltiple y tiene una amplia experiencia en modelos animales como en el modelo murino de EAE, el cual ser\u00e1 utilizado en este proyecto para estudiar la eficacia de ApSION<\/span><\/p>\n<\/td>\n<td>\n<figure id=\"attachment_604-3\" aria-describedby=\"caption-attachment-604-3\" style=\"width: 122px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-604\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png\" alt=\"\" width=\"122\" height=\"122\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png 401w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03-280x280.png 280w\" sizes=\"auto, (max-width: 122px) 100vw, 122px\" \/><figcaption id=\"caption-attachment-604-3\" class=\"wp-caption-text\">Desarrollo de terapias<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"115\">\n<p><a href=\"http:\/\/www.fbg.ub.edu\/en\/researchers\/research-groups-of-the-ub\/biochemistry-and-molecular-biology-of-cancer\/\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-917\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Bosch-i-Gimpera-795x400.jpg\" alt=\"\" width=\"795\" height=\"400\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Bosch-i-Gimpera-795x400.jpg 795w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Bosch-i-Gimpera-1400x705.jpg 1400w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Bosch-i-Gimpera-768x386.jpg 768w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Bosch-i-Gimpera-1536x773.jpg 1536w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Bosch-i-Gimpera.jpg 1711w\" sizes=\"auto, (max-width: 795px) 100vw, 795px\" \/><\/a><\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p><a href=\"http:\/\/www.fbg.ub.edu\/en\/researchers\/research-groups-of-the-ub\/biochemistry-and-molecular-biology-of-cancer\/\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1635\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/logo_UB.png\" alt=\"\" width=\"582\" height=\"159\" \/><\/a><\/p>\n<p>\u00a0<\/p>\n<\/td>\n<td width=\"115\">\n<p>\u00a0<\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/www.fbg.ub.edu\/en\/researchers\/research-groups-of-the-ub\/biochemistry-and-molecular-biology-of-cancer\/\" target=\"_blank\" rel=\"noopener\"><strong><span style=\"font-size: 110%;\">Fundaci\u00f3 Bosch i Gimpera\/ Universidad de Barcelona<\/span><\/strong><\/a><\/p>\n<p>\u00a0<\/p>\n<\/td>\n<td width=\"121\">\n<p><span style=\"font-size: 110%;\">Atrofia muscular asociada a Caquexia<\/span><\/p>\n<\/td>\n<td width=\"353\">\n<p>\u00a0<\/p>\n<p><span style=\"font-size: 110%;\">Los grupos del Dr.\u00a0 Josep Argil\u00e9s y la Dra. Silvia Busquets del Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular del C\u00e1ncer la Fundaci\u00f3 Bosch i Gimpera (Universidad de Barcelona) son expertos en modelos in vitro e in vivo de caquexia para el escrutinio de f\u00e1rmacos en esta indicaci\u00f3n. Colaboran en el desarrollo de nuevos f\u00e1rmacos para esta indicaci\u00f3n dentro del proyecto.<\/span><\/p>\n<p>\u00a0<\/p>\n<\/td>\n<td>\n<figure id=\"attachment_604-4\" aria-describedby=\"caption-attachment-604-4\" style=\"width: 122px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-604\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png\" alt=\"\" width=\"122\" height=\"122\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png 401w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03-280x280.png 280w\" sizes=\"auto, (max-width: 122px) 100vw, 122px\" \/><figcaption id=\"caption-attachment-604-4\" class=\"wp-caption-text\">Desarrollo de terapias<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"115\"><a href=\"http:\/\/fisabio.san.gva.es\/fisabio-oftamologia\"><span style=\"font-size: 110%;\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-633 aligncenter\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/logo_FISABIO.png\" alt=\"\" width=\"455\" height=\"149\" \/><\/span><\/a><\/td>\n<td style=\"text-align: center;\" width=\"115\"><a href=\"http:\/\/fisabio.san.gva.es\/fisabio-oftamologia\" target=\"_blank\" rel=\"noopener\"><strong><span style=\"font-size: 110%;\">\u00a0FISABIO<\/span><\/strong><\/a><\/td>\n<td width=\"121\">\n<p><span style=\"font-size: 110%;\">Distrofia de Fuchs<\/span><\/p>\n<\/td>\n<td width=\"353\">\n<p><span style=\"font-size: 110%;\">La Fundaci\u00f3n para el Fomento de la Investigaci\u00f3n Sanitaria y Biom\u00e9dica de la Comunitat Valenciana (FISABIO) colabora con el proyecto a trav\u00e9s del grupo de investigaci\u00f3n dirigido por la Dra. Cristina Peris,\u00a0 Directora M\u00e9dico\u00a0 de FISABIO oftatmolog\u00eda m\u00e9dica (FOM) y Profesora asociada Universidad de Val\u00e8ncia, centro de atenci\u00f3n especializada dedicada exclusivamente a la Oftalmolog\u00eda, especializado en cornea y enfermedades oft\u00e1lmicas externas.<\/span><\/p>\n<\/td>\n<td>\n<figure id=\"attachment_604-5\" aria-describedby=\"caption-attachment-604-5\" style=\"width: 122px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-604\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png\" alt=\"\" width=\"122\" height=\"122\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png 401w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03-280x280.png 280w\" sizes=\"auto, (max-width: 122px) 100vw, 122px\" \/><figcaption id=\"caption-attachment-604-5\" class=\"wp-caption-text\">Desarrollo de terapias<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"115\">\n<p><span style=\"font-size: 110%;\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-637\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/logo_IQS_Ramon_Llull.svg\" alt=\"\" width=\"1\" height=\"1\" \/> <a href=\"https:\/\/www.irycis.org\/es\/servicios\/22\/laboratorio-de-aptameros\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-638 aligncenter\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IRYCIS_Mayo_2020-800x295.png\" alt=\"\" width=\"800\" height=\"295\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IRYCIS_Mayo_2020-800x295.png 800w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IRYCIS_Mayo_2020-1400x516.png 1400w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IRYCIS_Mayo_2020-768x283.png 768w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IRYCIS_Mayo_2020-1536x566.png 1536w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IRYCIS_Mayo_2020-2048x755.png 2048w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><\/a><\/span><\/p>\n<\/td>\n<td width=\"115\">\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.irycis.org\/es\/servicios\/22\/laboratorio-de-aptameros\" target=\"_blank\" rel=\"noopener\"><strong><span style=\"font-size: 110%;\">Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria<\/span><\/strong><\/a><\/p>\n<\/td>\n<td width=\"121\">\n<p><span style=\"font-size: 110%;\">Apt\u00e1meros<\/span><\/p>\n<p><span style=\"font-size: 110%;\">S\u00edndrome Guillain-Barre<\/span><\/p>\n<p>\u00a0<\/p>\n<\/td>\n<td width=\"353\">\n<p><span style=\"font-size: 110%;\">El Grupo de Apt\u00e1meros del Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria, liderado por el Dr. V\u00edctor M. Gonz\u00e1lez, es el equipo pionero en el desarrollo de la tecnolog\u00eda de apt\u00e1meros en Espa\u00f1a.<\/span><\/p>\n<p>\u00a0<\/p>\n<\/td>\n<td>\n<figure id=\"attachment_604-6\" aria-describedby=\"caption-attachment-604-6\" style=\"width: 122px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-604\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png\" alt=\"\" width=\"122\" height=\"122\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03.png 401w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_03-280x280.png 280w\" sizes=\"auto, (max-width: 122px) 100vw, 122px\" \/><figcaption id=\"caption-attachment-604-6\" class=\"wp-caption-text\">Desarrollo de terapias<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"115\">\n<p><a href=\"https:\/\/www.iqs.edu\/es\/grupos-de-investigacion\/gemat\"><span style=\"font-size: 110%;\"><img decoding=\"async\" class=\"size-full wp-image-637 aligncenter\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/logo_IQS_Ramon_Llull.svg\" alt=\"\" \/><\/span><\/a><\/p>\n<\/td>\n<td width=\"115\">\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.iqs.edu\/es\/grupos-de-investigacion\/gemat\" target=\"_blank\" rel=\"noopener\"><strong><span style=\"font-size: 110%;\">Instituto de Qu\u00edmica de Sarria (IQS)<\/span><\/strong><\/a><\/p>\n<\/td>\n<td width=\"121\">\n<p><span style=\"font-size: 110%;\">Desarrollo de Nanopart\u00edculas<\/span><\/p>\n<p><span style=\"font-size: 110%;\">Escaldo industrial.<\/span><\/p>\n<\/td>\n<td width=\"353\">\n<p><span style=\"font-size: 110%;\">La investigaci\u00f3n est\u00e1 liderada por el Dr. Salvador Borros, Director General del IQS de la Universidad Ramon Llull y del grupo GEMAT. Su especializaci\u00f3n en se centra en la investigaci\u00f3n b\u00e1sica y aplicada y la transferencia orientada al tejido empresarial. En el proyecto participar para el desarrollo y sobre todo dar viabilidad al escalado de nanomateriales en aplicaci\u00f3n industrial.<\/span><\/p>\n<\/td>\n<td>\n<figure id=\"attachment_603\" aria-describedby=\"caption-attachment-603\" style=\"width: 122px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-603\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_02.png\" alt=\"\" width=\"122\" height=\"122\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_02.png 401w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_02-280x280.png 280w\" sizes=\"auto, (max-width: 122px) 100vw, 122px\" \/><figcaption id=\"caption-attachment-603\" class=\"wp-caption-text\">Nanotecnolog\u00eda y liberaci\u00f3n de f\u00e1rmacos<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"115\">\n<p><a href=\"https:\/\/nanociencia.imdea.org\/nanobiotechnology\/group-home\"><span style=\"font-size: 110%;\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-618 aligncenter\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IMDEA-800x267.jpg\" alt=\"\" width=\"800\" height=\"267\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IMDEA-800x267.jpg 800w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IMDEA-768x256.jpg 768w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Logo_IMDEA.jpg 1200w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><\/span><\/a><\/p>\n<\/td>\n<td width=\"115\">\n<p style=\"text-align: center;\"><a href=\"https:\/\/nanociencia.imdea.org\/nanobiotechnology\/group-home\" target=\"_blank\" rel=\"noopener\"><strong><span style=\"font-size: 110%;\">IMDEA-nanociencia<\/span><\/strong><\/a><\/p>\n<\/td>\n<td width=\"121\">\n<p><span style=\"font-size: 110%;\">Oligoniucle\u00f3tidos Bioconjugados<\/span><\/p>\n<\/td>\n<td width=\"353\">\n<p><span style=\"font-size: 110%;\">El grupo del Dr. \u00c1lvaro Somoza est\u00e1 especializado en la s\u00edntesis de \u00e1cidos nucleicos, nanopart\u00edculas y nanomedicina. Su funci\u00f3n en el proyecto en la conjugaci\u00f3n (uni\u00f3n) de otras mol\u00e9culas con oligonucle\u00f3tidos (bioconjugaci\u00f3n) con el fin de que alcancen las c\u00e9lulas de una manera eficiente<\/span><\/p>\n<\/td>\n<td>\n<figure id=\"attachment_603-2\" aria-describedby=\"caption-attachment-603-2\" style=\"width: 122px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-603\" src=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_02.png\" alt=\"\" width=\"122\" height=\"122\" srcset=\"https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_02.png 401w, https:\/\/oligofastx.com\/wp-content\/uploads\/2022\/07\/Inf_An_02-280x280.png 280w\" sizes=\"auto, (max-width: 122px) 100vw, 122px\" \/><figcaption id=\"caption-attachment-603-2\" class=\"wp-caption-text\">Nanotecnolog\u00eda y liberaci\u00f3n de f\u00e1rmacos<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1627051336 > .col-inner {\n  padding: 30px 40px 40px 30px;\n  margin: 8px 0px 0px 2px;\n  border-radius: 25px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t<section class=\"section\" id=\"section_1488897852\">\n\t\t<div class=\"bg section-bg fill bg-fill  bg-loaded\" >\n\n\t\t\t\n\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row\"  id=\"row-1924390648\">\n\n\t<div id=\"col-1774096462\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1488897852 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n}\n<\/style>\n\t<\/section>\n\t\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-blank.php","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-366","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/oligofastx.com\/es\/wp-json\/wp\/v2\/pages\/366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oligofastx.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oligofastx.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oligofastx.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oligofastx.com\/es\/wp-json\/wp\/v2\/comments?post=366"}],"version-history":[{"count":64,"href":"https:\/\/oligofastx.com\/es\/wp-json\/wp\/v2\/pages\/366\/revisions"}],"predecessor-version":[{"id":1669,"href":"https:\/\/oligofastx.com\/es\/wp-json\/wp\/v2\/pages\/366\/revisions\/1669"}],"wp:attachment":[{"href":"https:\/\/oligofastx.com\/es\/wp-json\/wp\/v2\/media?parent=366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}